Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000459564 | SCV000558403 | likely benign | Ataxia-telangiectasia syndrome | 2023-04-17 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000775803 | SCV000910256 | likely benign | Hereditary cancer-predisposing syndrome | 2018-01-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000775803 | SCV001187334 | likely benign | Hereditary cancer-predisposing syndrome | 2015-11-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003479131 | SCV004222871 | likely benign | not specified | 2023-11-03 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004591380 | SCV005083784 | benign | Familial cancer of breast | 2024-06-06 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |